Literature DB >> 23292636

TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database.

Lirong Wang1, Chao Ma, Peter Wipf, Haibin Liu, Weiwei Su, Xiang-Qun Xie.   

Abstract

Target identification of the known bioactive compounds and novel synthetic analogs is a very important research field in medicinal chemistry, biochemistry, and pharmacology. It is also a challenging and costly step towards chemical biology and phenotypic screening. In silico identification of potential biological targets for chemical compounds offers an alternative avenue for the exploration of ligand-target interactions and biochemical mechanisms, as well as for investigation of drug repurposing. Computational target fishing mines biologically annotated chemical databases and then maps compound structures into chemogenomical space in order to predict the biological targets. We summarize the recent advances and applications in computational target fishing, such as chemical similarity searching, data mining/machine learning, panel docking, and the bioactivity spectral analysis for target identification. We then described in detail a new web-based target prediction tool, TargetHunter (http://www.cbligand.org/TargetHunter). This web portal implements a novel in silico target prediction algorithm, the Targets Associated with its MOst SImilar Counterparts, by exploring the largest chemogenomical databases, ChEMBL. Prediction accuracy reached 91.1% from the top 3 guesses on a subset of high-potency compounds from the ChEMBL database, which outperformed a published algorithm, multiple-category models. TargetHunter also features an embedded geography tool, BioassayGeoMap, developed to allow the user easily to search for potential collaborators that can experimentally validate the predicted biological target(s) or off target(s). TargetHunter therefore provides a promising alternative to bridge the knowledge gap between biology and chemistry, and significantly boost the productivity of chemogenomics researchers for in silico drug design and discovery.

Mesh:

Substances:

Year:  2013        PMID: 23292636      PMCID: PMC3675739          DOI: 10.1208/s12248-012-9449-z

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  42 in total

1.  High content screening applied to large-scale cell biology.

Authors:  Vivek C Abraham; D Lansing Taylor; Jeffrey R Haskins
Journal:  Trends Biotechnol       Date:  2004-01       Impact factor: 19.536

2.  Do structurally similar molecules have similar biological activity?

Authors:  Yvonne C Martin; James L Kofron; Linda M Traphagen
Journal:  J Med Chem       Date:  2002-09-12       Impact factor: 7.446

3.  Use of genome-wide association studies for drug repositioning.

Authors:  Philippe Sanseau; Pankaj Agarwal; Michael R Barnes; Tomi Pastinen; J Brent Richards; Lon R Cardon; Vincent Mooser
Journal:  Nat Biotechnol       Date:  2012-04-10       Impact factor: 54.908

4.  Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.

Authors:  James H Nettles; Jeremy L Jenkins; Andreas Bender; Zhan Deng; John W Davies; Meir Glick
Journal:  J Med Chem       Date:  2006-11-16       Impact factor: 7.446

Review 5.  Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint.

Authors:  Andreas Bender; Daniel W Young; Jeremy L Jenkins; Martin Serrano; Dmitri Mikhailov; Paul A Clemons; John W Davies
Journal:  Comb Chem High Throughput Screen       Date:  2007-09       Impact factor: 1.339

6.  Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.

Authors:  Andreas Bender; Josef Scheiber; Meir Glick; John W Davies; Kamal Azzaoui; Jacques Hamon; Laszlo Urban; Steven Whitebread; Jeremy L Jenkins
Journal:  ChemMedChem       Date:  2007-06       Impact factor: 3.466

7.  Drug Repurposing from an Academic Perspective.

Authors:  Tudor I Oprea; Julie E Bauman; Cristian G Bologa; Tione Buranda; Alexandre Chigaev; Bruce S Edwards; Jonathan W Jarvik; Hattie D Gresham; Mark K Haynes; Brian Hjelle; Robert Hromas; Laurie Hudson; Debra A Mackenzie; Carolyn Y Muller; John C Reed; Peter C Simons; Yelena Smagley; Juan Strouse; Zurab Surviladze; Todd Thompson; Oleg Ursu; Anna Waller; Angela Wandinger-Ness; Stuart S Winter; Yang Wu; Susan M Young; Richard S Larson; Cheryl Willman; Larry A Sklar
Journal:  Drug Discov Today Ther Strateg       Date:  2011

8.  Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking, enzymatic assay, and X-ray crystallography validation.

Authors:  Jianhua Cai; Cong Han; Tiancen Hu; Jian Zhang; Dalei Wu; Fangdao Wang; Yunqing Liu; Jianping Ding; Kaixian Chen; Jianmin Yue; Xu Shen; Hualiang Jiang
Journal:  Protein Sci       Date:  2006-08-01       Impact factor: 6.725

9.  Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing.

Authors:  Wade S Blair; Joan Cao; Lynn Jackson; Judith Jimenez; Qinghai Peng; Hua Wu; Jason Isaacson; Scott L Butler; Alex Chu; Joanne Graham; Anne-Marie Malfait; Micky Tortorella; Amy K Patick
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

10.  Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining.

Authors:  Tiejun Cheng; Qingliang Li; Yanli Wang; Stephen H Bryant
Journal:  J Chem Inf Model       Date:  2011-08-18       Impact factor: 4.956

View more
  63 in total

1.  Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.

Authors:  Mariusz Butkiewicz; Alice L Rodriguez; Shane E Rainey; Joshua Wieting; Vincent B Luscombe; Shaun R Stauffer; Craig W Lindsley; P Jeffrey Conn; Jens Meiler
Journal:  ACS Chem Neurosci       Date:  2019-06-17       Impact factor: 4.418

2.  Validation strategies for target prediction methods.

Authors:  Neann Mathai; Ya Chen; Johannes Kirchmair
Journal:  Brief Bioinform       Date:  2020-05-21       Impact factor: 11.622

3.  Development and Testing of Druglike Screening Libraries.

Authors:  Junmei Wang; Yubin Ge; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2019-01-03       Impact factor: 4.956

4.  Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis.

Authors:  Yuan-Qiang Wang; Wei-Wei Lin; Nan Wu; Si-Yi Wang; Mao-Zi Chen; Zhi-Hua Lin; Xiang-Qun Xie; Zhi-Wei Feng
Journal:  Acta Pharmacol Sin       Date:  2019-02-27       Impact factor: 6.150

5.  Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study.

Authors:  Xiaomeng Xu; Shifan Ma; Zhiwei Feng; Guanxing Hu; Lirong Wang; Xiang-Qun Xie
Journal:  J Mol Graph Model       Date:  2016-08-08       Impact factor: 2.518

6.  DAKB-GPCRs: An Integrated Computational Platform for Drug Abuse Related GPCRs.

Authors:  Maozi Chen; Yankang Jing; Lirong Wang; Zhiwei Feng; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2019-03-14       Impact factor: 4.956

7.  StemCellCKB: An Integrated Stem Cell-Specific Chemogenomics KnowledgeBase for Target Identification and Systems-Pharmacology Research.

Authors:  Yu Zhang; Lirong Wang; Zhiwei Feng; Haizi Cheng; Terence Francis McGuire; Yahui Ding; Tao Cheng; Yingdai Gao; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2016-10-07       Impact factor: 4.956

8.  The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis.

Authors:  Ying Xue; Zhi-Wei Feng; Xiao-Ye Li; Zi-Heng Hu; Qing Xu; Zi Wang; Jia-Hui Cheng; Hong-Tao Shi; Qi-Bing Wang; Hong-Yi Wu; Xiang-Qun Xie; Qian-Zhou Lv
Journal:  Acta Pharmacol Sin       Date:  2017-09-21       Impact factor: 6.150

9.  Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.

Authors:  Filip Miljković; Jürgen Bajorath
Journal:  J Comput Aided Mol Des       Date:  2019-12-02       Impact factor: 3.686

10.  Computational target fishing: what should chemogenomics researchers expect for the future of in silico drug design and discovery?

Authors:  Lirong Wang; Xiang-Qun Xie
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.